Raab & Moskowitz Asset Management’s Zimmer Biomet ZBH Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-275	Closed	-$39K	–	534
2019 Q4	$39K	Buy	+275	New	+$38K	0.02%	282
2018 Q4	–	Sell	-275	Closed	-$35K	–	519
2018 Q3	$35K	Buy	+275	New	+$32.7K	0.01%	289
2015 Q1	–	Sell	-275	Closed	-$30K	–	386
2014 Q4	$30K	Buy	+275	New	+$29K	0.02%	242

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Raab & Moskowitz Asset Management's ZBH Position: Q1 2020 in Review

Raab & Moskowitz Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 275 shares — an estimated $39K sold.

Raab & Moskowitz Asset Management first reported a position in ZBH in Q4 2014 and held it in 3 quarters. The position peaked at $39K in Q4 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

Raab & Moskowitz Asset Management reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
Raab & Moskowitz Asset Management sold 275 Zimmer Biomet shares in Q1 2020, an estimated $39K.
Raab & Moskowitz Asset Management first reported a position in Zimmer Biomet in Q4 2014 and held it in 3 quarters.
Raab & Moskowitz Asset Management's Zimmer Biomet position peaked at $39K in Q4 2019.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2020, filed 14 May 2020.